Rituximab Linked to High Hypogammaglobulinemia Rates in Real-World Cohort
A retrospective study in Mexico found that 42.9% of patients treated with rituximab developed secondary hypogammaglobulinemia, highlighting the need for ...
A retrospective study in Mexico found that 42.9% of patients treated with rituximab developed secondary hypogammaglobulinemia, highlighting the need for ...
Clinicians achieved sustained remission using salvage multi-agent chemotherapy in a patient with Sjögren's disease complicated by severe TAFRO syndrome.
A systematic review of cohort studies suggests rituximab may offer benefits for severe central nervous system involvement in Sjögren’s disease, ...
A case report details concurrent longitudinally extensive transverse myelitis and acute sensorimotor polyneuropathy following hepatitis B virus reactivation after rituximab-containing ...
A meta-analysis of 753 patients shows rituximab remission rates vary significantly by kidney pathology and prior treatment response, supporting precision-based ...
A single-center retrospective study of 20 kidney transplant recipients found that combined plasmapheresis and rituximab induced proteinuria remission in 65 ...
A case report details a patient who developed delayed rituximab-induced serum sickness eight days after experiencing an immediate anaphylactic reaction ...
A Japanese case series reports that three men with follicular lymphoma treated with anti-CD20 antibodies improved after ensitrelvir when remdesivir ...
A clinical report details a patient with metastatic breast cancer who developed a rare chronic immune-mediated polyradiculoneuropathy with anti-neurofascin antibodies ...
In a multicenter retrospective study of 149 French patients with anti-MAG neuropathy, 36 percent experienced long-term functional improvement following rituximab ...
A new review maps how a clonal B-cell disorder and complement-driven hemolysis define cold agglutinin disease, why steroids and splenectomy ...
A new comparative review finds that the type II anti-CD20 antibody obinutuzumab succeeded in Phase 3 lupus trials where rituximab ...
A computational study built a gut microbiota–metabolite–host gene score that stratified rheumatoid arthritis patients into two molecular subtypes and predicted ...
A network meta-analysis of 15 randomized trials ranks telitacicept highest for SRI-4 response in lupus but links it to more ...
A decade-long multicenter study of 483 patients identifies age and Lugano stage as the only independent predictors of survival in ...
Eleven new studies on ANCA-associated vasculitis reveal transient pandemic-era incidence shifts, qualitative B-cell immune signatures, checkpoint biomarkers predicting rituximab failure, ...
In a retrospective case series of seven Chinese children with ROHHAD syndrome, all patients showed the defining triad of rapid-onset ...
A Bayesian reanalysis of the RELEVANCE trial found extremely low probabilities that rituximab plus lenalidomide was inferior to rituximab plus ...
A 46-year-old man's painless lymph node swelling led to a failed treatment course for Castleman disease before clinicians recognized IgG4-related ...
A population-based Ontario study found limited survival among older mantle cell lymphoma patients ineligible for autologous stem cell transplantation, with ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.